newsfilter
← Latest News
GlobeNewswire·

Alumis to Present at Leerink's 2025 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes